Inventage Lab, Inc.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Public
- Established
- 2015-05-14
- Employees
- 69
- Market Cap
- -
- Website
- http://www.inventagelab.com
Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Phase 1
3 (100.0%)A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
Phase 1
Recruiting
- Conditions
- Opioid DependenceAlcohol DependenceMultiple Sclerosis
- Interventions
- First Posted Date
- 2022-11-17
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- Inventage Lab., Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05620940
- Locations
- π¦πΊ
Nucleus Network, Herston, Queensland, Australia
A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.
Phase 1
Active, not recruiting
- Conditions
- Alzheimer Disease
- Interventions
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Inventage Lab., Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT05345509
- Locations
- π¦πΊ
Nucleus Network, Melbourne, Australia
A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
Phase 1
Completed
- Conditions
- Androgenetic Alopecia
- Interventions
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Inventage Lab., Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04945226
- Locations
- π¦πΊ
Nucleus Network, Brisbane, Australia
News
No news found